BRCA1相关乳腺癌的临床前小鼠模型
Preclinical mouse models for BRCA1-associated breast cancer.
作者信息
Drost R M, Jonkers J
机构信息
Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.
出版信息
Br J Cancer. 2009 Nov 17;101(10):1651-7. doi: 10.1038/sj.bjc.6605350. Epub 2009 Sep 29.
Abstract
A substantial part of all hereditary breast cancer cases is caused by BRCA1 germline mutations. In this review, we will discuss the insights into BRCA1 functions that we obtained from mouse models with conventional and conditional mutations in Brca1. The most advanced models closely resemble human BRCA1-related breast cancer and may therefore be useful for addressing clinically relevant questions.
摘要
所有遗传性乳腺癌病例中有很大一部分是由BRCA1种系突变引起的。在本综述中，我们将讨论从Brca1具有常规和条件性突变的小鼠模型中获得的关于BRCA1功能的见解。最先进的模型与人类BRCA1相关乳腺癌非常相似，因此可能有助于解决临床相关问题。
相似文献
1
Preclinical mouse models for BRCA1-associated breast cancer.BRCA1相关乳腺癌的临床前小鼠模型
Br J Cancer. 2009 Nov 17;101(10):1651-7. doi: 10.1038/sj.bjc.6605350. Epub 2009 Sep 29.
2
Studying therapy response and resistance in mouse models for BRCA1-deficient breast cancer.研究 BRCA1 缺陷型乳腺癌小鼠模型中的治疗反应和耐药性。
J Mammary Gland Biol Neoplasia. 2011 Apr;16(1):41-50. doi: 10.1007/s10911-011-9199-z. Epub 2011 Feb 18.
3
BRCA genes: lessons learned from experimental and clinical cancer.BRCA 基因：从实验和临床癌症中获得的经验教训。
Ann Oncol. 2011 Jan;22 Suppl 1:i7-10. doi: 10.1093/annonc/mdq659.
4
BRCA1-associated tumorigenesis: what have we learned from knockout mice?BRCA1相关的肿瘤发生：我们从基因敲除小鼠中学到了什么？
Trends Genet. 2001 Oct;17(10):S18-22. doi: 10.1016/s0168-9525(01)02451-9.
5
Mouse models of BRCA1 and their application to breast cancer research.BRCA1 基因的小鼠模型及其在乳腺癌研究中的应用。
Cancer Metastasis Rev. 2013 Jun;32(1-2):25-37. doi: 10.1007/s10555-012-9403-7.
6
Special considerations in mouse models of breast cancer.乳腺癌小鼠模型中的特殊考量。
Breast Dis. 2007;28:29-38. doi: 10.3233/bd-2007-28104.
7
Generation and analysis of Brca1 conditional knockout mice.Brca1条件性敲除小鼠的产生与分析
Methods Mol Biol. 2004;280:185-200. doi: 10.1385/1-59259-788-2:185.
8
Breast cancer genes: therapeutic strategies.乳腺癌基因：治疗策略。
Ann N Y Acad Sci. 1997 Dec 29;833:34-41. doi: 10.1111/j.1749-6632.1997.tb48590.x.
9
Emerging roles of BRCA1 in transcriptional regulation and DNA repair.BRCA1在转录调控和DNA修复中的新作用。
J Cell Physiol. 1999 Dec;181(3):385-92. doi: 10.1002/(SICI)1097-4652(199912)181:3<385::AID-JCP2>3.0.CO;2-4.
10
Genetically engineered rat models for breast cancer.用于乳腺癌研究的基因工程大鼠模型。
Breast Dis. 2007;28:53-61. doi: 10.3233/bd-2007-28106.
引用本文的文献
1
Epigenetic scars of Brca1 loss point toward breast cancer cell of origin.Brca1缺失的表观遗传疤痕指向乳腺癌起源细胞。
Nat Genet. 2024 Dec;56(12):2594-2595. doi: 10.1038/s41588-024-02021-0.
2
The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers.抑癌基因 BRCA1/2、妇科和乳腺肿瘤的癌症易感性和基因组不稳定性。
Asian Pac J Cancer Prev. 2023 Sep 1;24(9):3139-3153. doi: 10.31557/APJCP.2023.24.9.3139.
3
Brca1 rat is a novel model of human BRCA1 deficiency displaying susceptibility to radiation-induced mammary cancer.Brca1 大鼠是一种新型的人类 BRCA1 缺陷模型，表现出对辐射诱导的乳腺癌的易感性。
Cancer Sci. 2022 Oct;113(10):3362-3375. doi: 10.1111/cas.15485. Epub 2022 Aug 21.
4
Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway.BRCA1 功能丧失通过激活 TGFβR2 信号通路促进乳腺肿瘤 EMT。
Cell Death Dis. 2022 Mar 2;13(3):195. doi: 10.1038/s41419-022-04646-7.
5
Pathogenesis of Triple-Negative Breast Cancer.三阴性乳腺癌的发病机制。
Annu Rev Pathol. 2022 Jan 24;17:181-204. doi: 10.1146/annurev-pathol-042420-093238.
6
Histological Findings of Mammary Gland Development and Risk of Breast Cancer in Mutant Mouse Models.突变小鼠模型中乳腺发育的组织学发现与乳腺癌风险
J Breast Cancer. 2021 Oct;24(5):455-462. doi: 10.4048/jbc.2021.24.e44. Epub 2021 Oct 5.
7
GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer.GATA3 通过 BRCA1 下游发挥作用，抑制乳腺癌中的 EMT。
Theranostics. 2021 Jul 13;11(17):8218-8233. doi: 10.7150/thno.59280. eCollection 2021.
8
Mouse Models for Deciphering the Impact of Homologous Recombination on Tumorigenesis.用于解读同源重组对肿瘤发生影响的小鼠模型
Cancers (Basel). 2021 Apr 25;13(9):2083. doi: 10.3390/cancers13092083.
9
and Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis.并且缺陷使卵巢癌对铂类疗法敏感并带来更好的预后。
Biomedicines. 2021 Feb 18;9(2):207. doi: 10.3390/biomedicines9020207.
10
ENCORE: A Visualization Tool for Insight into Circadian Omics.ENCORE：一种用于洞察昼夜节律组学的可视化工具。
ACM BCB. 2019 Sep;2019:5-14. doi: 10.1145/3307339.3342137.
本文引用的文献
1
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.对携带BRCA突变的肿瘤中聚（ADP - 核糖）聚合酶的抑制作用。
N Engl J Med. 2009 Jul 9;361(2):123-34. doi: 10.1056/NEJMoa0900212. Epub 2009 Jun 24.
2
High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.BRCA1相关乳腺癌中蛋白质截短型TP53突变的高发生率。
Cancer Res. 2009 Apr 15;69(8):3625-33. doi: 10.1158/0008-5472.CAN-08-3426. Epub 2009 Mar 31.
3
High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors.TP53突变在BRCA1相关和散发性基底样乳腺癌中频率较高，但在BRCA1管腔型乳腺肿瘤中并非如此。
Cancer Res. 2009 Jan 15;69(2):663-71. doi: 10.1158/0008-5472.CAN-08-1560.
4
E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks.BRCA1的E3连接酶活性对于哺乳动物细胞的生存能力或双链DNA断裂的同源定向修复并非必不可少。
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20876-81. doi: 10.1073/pnas.0811203106. Epub 2008 Dec 16.
5
Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1.鉴定和功能分析新的 BRCA1 转录本，包括小鼠 Brca1-Iris 和人源伪 BRCA1。
Breast Cancer Res Treat. 2010 Jan;119(1):239-47. doi: 10.1007/s10549-008-0256-2. Epub 2008 Dec 9.
6
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs.BRCA1缺陷型乳腺肿瘤对PARP抑制剂AZD2281单独使用以及与铂类药物联合使用具有高度敏感性。
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17079-84. doi: 10.1073/pnas.0806092105. Epub 2008 Oct 29.
7
"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.卵巢癌中的“BRCA样”综合征：一项病例对照研究，描述与BRCA1和BRCA2突变相关的上皮性卵巢癌患者的临床特征和预后。
J Clin Oncol. 2008 Dec 1;26(34):5530-6. doi: 10.1200/JCO.2008.16.1703. Epub 2008 Oct 27.
8
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients.BRCA1 阳性乳腺癌患者对顺铂新辅助治疗的反应。
Breast Cancer Res Treat. 2009 May;115(2):359-63. doi: 10.1007/s10549-008-0128-9. Epub 2008 Jul 23.
9
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.癌症干细胞在Brca1/p53介导的小鼠乳腺肿瘤中导致顺铂耐药。
Cancer Res. 2008 May 1;68(9):3243-50. doi: 10.1158/0008-5472.CAN-07-5480.
10
The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression.由Brca1或Bard1失活诱导产生的基底样乳腺癌表明BRCA1/BARD1异二聚体具有肿瘤抑制作用。
Proc Natl Acad Sci U S A. 2008 May 13;105(19):7040-5. doi: 10.1073/pnas.0711032105. Epub 2008 Apr 28.
Zotero 插件